Date Title  
Jul 27, 2021
Summary ToggleSol-Gel Technologies Announces FDA Approval of TWYNEO®
 
Jul 20, 2021
Summary ToggleSol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
 
Jun 28, 2021
Summary ToggleSol-Gel Announces Pipeline Update and Future Development Plans
 
Jun 28, 2021
Summary ToggleSol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
 
May 27, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human Health Innovation Conference
 
May 13, 2021
Summary ToggleSol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
 
Apr 27, 2021
Summary ToggleSol-Gel Technologies Provides Update on FDA Review of EPSOLAY®
 
Mar 04, 2021
Summary ToggleSol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update
 
Feb 24, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference
 
Jan 11, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference
 
Displaying 1 - 10 of 72 results